Larvol Delta - GRECO1-Phase-III-Study-of-SBRT-and-GC4711-for-Centrally-Located-or-Large-NSCLC

rucosopasem manganese (GC4711) - Galera Therap

http://clinicaltrials.gov/ct2/show/NCT04476797

Dec 13, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next